Related Experiment Video
Updated: Feb 2, 2026

Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated
Jia Xu1,2, Long Pang1, Xiao Xue Ma3
1Department of Medical Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, PR China.
Abstract:
Vancomycin has been the primary agent used to treat serious Methicillin-resistant Staphylococcus aureus (MRSA) infection for many years. However, the rise of MRSA infection rates and the extensive use of vancomycin have led to the emergence of reduced vancomycin susceptibility. Therefore, four typical Staphylococcus aureus (S. aureus) strains from different clinical specimens were derivated by vancomycin in vitro to better clarify their phenotypic and molecular characteristics. Some experiments, such as stepwise selection of vancomycin-resistant strains, pulsed-field gel electrophoresis (PFGE), antimicrobial susceptibility test, population analysis profile-area under the curve (PAP-AUC), molecular typing, transmission electron microscopy, δ-hemolysin expression, autolysis assay, biofilm assay and quantitative real-time polymerase chain reaction (qPCR) for gene expression were carried out to compare the derivated bacteria with their parental strains. Results showed that the observed phenotypes of vancomycin-resistant strains such as hemolysin, autolysis and biofilm significantly reduced, which were associated with vancomycin resistance capability of the selected strain. The changes of phenotype and regulatory genes expression were inversely proportional to the vancomycin minimum inhibitory concentration (MICvan). Most heterogeneous vancomycin intermediate Staphylococcus aureus (hVISA) or VISA strains belonged to spa type t570 and agr group II. In summary, the clinical isolated vancomycin susceptible Staphylococcus aureus (VSSA), hVISA and VISA could be derivated into high vancomycin-resistant VISA in vitro, but it was difficult for them to develop into vancomycin resistant Staphylococcus aureus (VRSA). VISA and hVISA could gradually adapt to the environment with the vancomycin concentration that continuously elevates.
Insights
Vancomycin resistance in Staphylococcus aureus is increasing. In vitro studies show that while vancomycin-intermediate strains can develop higher resistance, they rarely become fully resistant (VRSA).
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Vancomycin is a critical antibiotic for treating Methicillin-resistant Staphylococcus aureus (MRSA) infections.
- Increasing MRSA rates and vancomycin use have led to reduced susceptibility, including vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA).
- Understanding the mechanisms and limitations of vancomycin resistance development is crucial for effective treatment strategies.
Purpose of the Study:
- To investigate the phenotypic and molecular characteristics of Staphylococcus aureus strains derived for vancomycin resistance in vitro.
- To compare vancomycin-resistant strains with their parental strains regarding various biological and genetic factors.
- To determine the potential for vancomycin-susceptible strains to evolve into high-level vancomycin resistance.
Main Methods:
- Stepwise in vitro selection of vancomycin-resistant Staphylococcus aureus strains.
- Antimicrobial susceptibility testing, including population analysis profile-area under the curve (PAP-AUC).
- Molecular typing (PFGE, spa typing), gene expression analysis (qPCR), and phenotypic assays (hemolysin, autolysis, biofilm).
Main Results:
- Derived vancomycin-resistant strains exhibited reduced hemolysin, autolysis, and biofilm formation.
- Changes in phenotype and gene expression were inversely proportional to vancomycin minimum inhibitory concentration (MICvan).
- Most hVISA/VISA strains belonged to spa type t570 and agr group II; derivation to high-level VISA was possible, but not to VRSA.
Conclusions:
- In vitro derivation of vancomycin resistance in Staphylococcus aureus leads to significant phenotypic alterations.
- While intermediate resistance can increase, the development of high-level vancomycin resistance (VRSA) is challenging to achieve in vitro.
- VISA and hVISA strains demonstrate adaptability to increasing vancomycin concentrations, highlighting the dynamic nature of antimicrobial resistance.
Related Concept Videos
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Predicting Molecular Geometry
Susceptibility, Permittivity and Dielectric Constant
Molecular Models

